Japanese Device Makers Unite To Develop Heart Pump In U.S.
This article was originally published in PharmAsia News
Executive Summary
Japanese medical device makers Asahi Kasei and Misuzu & Sun Medical Holdings have entered into an agreement to develop and market Misuzu's implantable heart-assist device in the United States and elsewhere. Under the agreement, Asahi Kasei bought a 60 percent stake in Misuzu's U.S. subsidiary, Evaheart Medical USA for $7.5 million and is to cover the cost of clinical trials in the United States. The device under development is Misuzu's left ventricular assist system that helps the heart circulate blood via an implantable pump. The firm already has applied for approval in Japanese. (Click here for more - a subscription may be required)